medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-8-63-67medsovet-1308Research ArticleКЛИНИЧЕСКИЙ ОБЗОРCLINICAL REVIEWВопросы патогенеза и лечения постинсультной спастичностиQuestions of pathogenesis and treatment of post-stroke spasticityЗиновьеваО. Е.ZinovyevaO. E.noemail@neicon.ruГоловачеваВ. А.GolovachevaV. A.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation201630122016086367Copyright © Зиновьева О.Е., Головачева В.А., 20162016Зиновьева О.Е., Головачева В.А.Zinovyeva O.E., Golovacheva V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1308

Постинсультная спастичность в значительной степени ограничивает двигательные возможности пациентов, затрудняет уход за больными, способствует формированию болевых синдромов. В статье приведены современные представления о патогенезе церебральной спастичности, обсуждаются основные лечебно-реабилитационные мероприятия. Подробно рассматривается возможность использования ботулинического токсина типа А для коррекции повышенного мышечного тонуса у пациентов, перенесших инсульт.

Post-stroke spasticity considerably limits the ability to move for patients, hinders nursing, and contributes to the formation of pain syndromes. The article tells about the current understanding of the pathogenesis of cerebral spasticity, and discusses baseline treatment and rehabilitation activities. Administration of botulinum toxin type A for managing increased muscle tone in patients with stroke is considered in detail.

постинсультная спастичностьпатогенезлечениеботулинотерапияpost-stroke spasticitypathogenesistreatmentbotulinum therapyReferencesFrancisco GE, McGuire JR. Poststroke spasticity management. Stroke, 2012, 43(1): 3132-3136.Francisco GE, McGuire JR. Poststroke spasticity management. Stroke, 2012, 43(1): 3132-3136.Ryu J, Lee J, Lee S et al. Factors predictive of spasticity and their effects on motor recovery and functional outcomes in stroke patients. Top Stroke Rehabil, 2010, 17: 380-8.Ryu J, Lee J, Lee S et al. Factors predictive of spasticity and their effects on motor recovery and functional outcomes in stroke patients. Top Stroke Rehabil, 2010, 17: 380-8.O'Dwyer N. J., Ada L., Neilson P.D. Spasticity and muscle contracture following stroke. Brain, 1996, 119: 1737-1749.O'Dwyer N. J., Ada L., Neilson P.D. Spasticity and muscle contracture following stroke. Brain, 1996, 119: 1737-1749.Pantano P, Formisano R, Ricci M et al. Motor recovery after stroke. Morphological and functional brain alterations. Brain, 1996, 119: 1849-1857.Pantano P, Formisano R, Ricci M et al. Motor recovery after stroke. Morphological and functional brain alterations. Brain, 1996, 119: 1849-1857.Sommerfeld D, Eek E, Svensson A. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke, 2004, 35: 134-9.Sommerfeld D, Eek E, Svensson A. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke, 2004, 35: 134-9.Кадыков А.С., Шахпаронова Н.В. Спастичность как проблема двигательной реабилитации: роль миорелаксантов. Неврология и ревматология, 2014, 1: 56-59.Кадыков А.С., Шахпаронова Н.В. Спастичность как проблема двигательной реабилитации: роль миорелаксантов. Неврология и ревматология, 2014, 1: 56-59.Blicher JU, Jakobsen J, Andersen G et al. Cortical excitability in chronic stroke and modulation by training: a TMS study. Neurorehabil. Neural. Repair., 2009, 23: 486-493.Blicher JU, Jakobsen J, Andersen G et al. Cortical excitability in chronic stroke and modulation by training: a TMS study. Neurorehabil. Neural. Repair., 2009, 23: 486-493.Gracies J.M. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve, 2005, 31: 535-551.Gracies J.M. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve, 2005, 31: 535-551.Lotze M, Markert J, Sauseng P et al. The role of multiple contralesional motor areas for complex hand movements after internal capsular lesion. J. Neuroscience, 2006, 26: 6096-6102.Lotze M, Markert J, Sauseng P et al. The role of multiple contralesional motor areas for complex hand movements after internal capsular lesion. J. Neuroscience, 2006, 26: 6096-6102.Завалишин И.А., Бархатова В.П. Спастичность. Журн. неврол. и психиатрии им. С.С. Корсакова, 1997, 97(3): 68-70.Завалишин И.А., Бархатова В.П. Спастичность. Журн. неврол. и психиатрии им. С.С. Корсакова, 1997, 97(3): 68-70.Клюшников С.А., Иллариошкин С.Н., Иванова-Смоленская И.А. Спастический синдром в неврологии. Возможности толперизона (Мидокалма) в терапии спастических проявлений нейроваскулярных синдромов. Атмосфера. Нервные болезни, 2009, 3: 39-44.Клюшников С.А., Иллариошкин С.Н., Иванова-Смоленская И.А. Спастический синдром в неврологии. Возможности толперизона (Мидокалма) в терапии спастических проявлений нейроваскулярных синдромов. Атмосфера. Нервные болезни, 2009, 3: 39-44.Milanov I. Clinical and neurophysiological correlations of spasticity. Funct Neurol, 1999, 14: 193-201.Milanov I. Clinical and neurophysiological correlations of spasticity. Funct Neurol, 1999, 14: 193-201.Huang CY, Wang CH, Hwang IS. Characterization of the mechanical and neural components of spastic hypertonia with modified H reflex. J Electromyogr Kinesiol., 2006, 16: 384-391.Huang CY, Wang CH, Hwang IS. Characterization of the mechanical and neural components of spastic hypertonia with modified H reflex. J Electromyogr Kinesiol., 2006, 16: 384-391.Зиновьева О.Е., Катушкина Э.А., Яхно Н.Н., и др. Изменения скелетных мышц при постинсультной спастичности. Неврологический журнал, 2011, 4: 19-26.Зиновьева О.Е., Катушкина Э.А., Яхно Н.Н., и др. Изменения скелетных мышц при постинсультной спастичности. Неврологический журнал, 2011, 4: 19-26.Chardon MK, Suresh NL, Rymer WZ. An evaluation of passive properties of spastic muscles in hemiparetic stroke survivors. Conf Proc IEEE Eng Med Biol Soc, 2010, 2010: 2993-2996.Chardon MK, Suresh NL, Rymer WZ. An evaluation of passive properties of spastic muscles in hemiparetic stroke survivors. Conf Proc IEEE Eng Med Biol Soc, 2010, 2010: 2993-2996.Ситнова М.А., Есин О.Р., Ресин РГ Постинсультная боль в области плеча: патогенез, принципы лечения. Практическая медицина, 2014, 2: 53-57.Ситнова М.А., Есин О.Р., Ресин РГ Постинсультная боль в области плеча: патогенез, принципы лечения. Практическая медицина, 2014, 2: 53-57.Matsumoto S, Kawahira K, Etoh S еt al. Short-term effects of thermotherapy for spasticity on tibial nerve F-waves in post-stroke patients. Int. J. Biometeorol., 2006, 50(4): 243-250.Matsumoto S, Kawahira K, Etoh S еt al. Short-term effects of thermotherapy for spasticity on tibial nerve F-waves in post-stroke patients. Int. J. Biometeorol., 2006, 50(4): 243-250.Thrasher TA, Popovic MR. Functional electrical stimulation of walking: function, exercise and rehabilitation. Annales de readaptation et de medecine physique, 2008, 51: 452-460.Thrasher TA, Popovic MR. Functional electrical stimulation of walking: function, exercise and rehabilitation. Annales de readaptation et de medecine physique, 2008, 51: 452-460.Fink M, Rollnik JD, Bijak M et al. Needle acupuncture in chronic poststroke leg spasticity. Arch. Phys. Med. Rehabil., 2004, 85(4): 667-672.Fink M, Rollnik JD, Bijak M et al. Needle acupuncture in chronic poststroke leg spasticity. Arch. Phys. Med. Rehabil., 2004, 85(4): 667-672.Mohammad Y, Zahra G, Hanieh M et al. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity. Iranian journal of neurology, 2013, 12(2): 47-50.Mohammad Y, Zahra G, Hanieh M et al. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity. Iranian journal of neurology, 2013, 12(2): 47-50.Simon O, Yelnik AP Managing spasticity with drugs. European journal of physiology and rehabilitation medicine, 2010, 46(3): 401-410.Simon O, Yelnik AP Managing spasticity with drugs. European journal of physiology and rehabilitation medicine, 2010, 46(3): 401-410.Yazdchi M, Ghasemi Z, Moshayedi H et al. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity. Iranian journal of neurology, 2013, 12(2): 47-50.Yazdchi M, Ghasemi Z, Moshayedi H et al. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity. Iranian journal of neurology, 2013, 12(2): 47-50.Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology, 1995, 45: 712-717.Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology, 1995, 45: 712-717.Rashear AB, Gordon MF, Elovic E et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spastic-ity after a stroke. N. Engl. J. Med., 2002, 347: 395-400.Rashear AB, Gordon MF, Elovic E et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spastic-ity after a stroke. N. Engl. J. Med., 2002, 347: 395-400.Yelnik AP, Colle FM, Bonan IV et al. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J. Neurol. Neurosurg. Psychiatry, 2007, 78: 845-848.Yelnik AP, Colle FM, Bonan IV et al. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J. Neurol. Neurosurg. Psychiatry, 2007, 78: 845-848.Cardoso E, Pedreira G, Prazeres A et al. Does botulinum toxin improve the function of the patient with spasticity after stroke? Arq. Neuropsiquiatr., 2007, 65(3-A): 592-595.Cardoso E, Pedreira G, Prazeres A et al. Does botulinum toxin improve the function of the patient with spasticity after stroke? Arq. Neuropsiquiatr., 2007, 65(3-A): 592-595.Парфенов В.А. Применение ботулинического токсина при постинсультной спастичности. Клиническая геронтология, 2001, 7(3-4): 46-49.Парфенов В.А. Применение ботулинического токсина при постинсультной спастичности. Клиническая геронтология, 2001, 7(3-4): 46-49.Bakheit AMO, Thilmann AF, Ward AB et al. A randomized, double-blind, placebo-controlled, dose ranging study to compare the efficacy and safety of three doses of Botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke, 2000, 31: 2402-2406.Bakheit AMO, Thilmann AF, Ward AB et al. A randomized, double-blind, placebo-controlled, dose ranging study to compare the efficacy and safety of three doses of Botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke, 2000, 31: 2402-2406.Ward AB. Spasticity treatment with botulinum toxin. Turk J Med Rehab, 2007, 53(Suppl 2): 6-12.Ward AB. Spasticity treatment with botulinum toxin. Turk J Med Rehab, 2007, 53(Suppl 2): 6-12.Хатькова С.Е. Использование ботулотоксина (ботокс) при лечении больных с постинсультной спастичностью. Журн. неврология и психиатрия им. С.С. Корсакова, 2009, 109(6): 87-90.Хатькова С.Е. Использование ботулотоксина (ботокс) при лечении больных с постинсультной спастичностью. Журн. неврология и психиатрия им. С.С. Корсакова, 2009, 109(6): 87-90.Ward AB, Wissel J, Borg J et al. Functional goal achievement in post-stroke spasticity patients: The Botox Economic Spasticity Trial (BEST). J Rehabil Med, 2014, 46: 504-513.Ward AB, Wissel J, Borg J et al. Functional goal achievement in post-stroke spasticity patients: The Botox Economic Spasticity Trial (BEST). J Rehabil Med, 2014, 46: 504-513.Barnes MR. Management of spasticity. Age and Ageing, 1998, 27: 239-245.Barnes MR. Management of spasticity. Age and Ageing, 1998, 27: 239-245.

The authors declare that there are no conflicts of interest present.